🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the overall survival of brivanib ve...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2009-05
Trial ID
NCT00858871
The purpose of this study is to determine if gastric/esophageal, lung, panc...
Status
Completed
Location
University Of Chicago
Start Date
2008-06
Trial ID
NCT00633789
The purpose of this study is to compare the Overall Survival (OS) of HCC pa...
Status
Completed
Location
Richard Finn, M.D.
Start Date
2009-07-20
Trial ID
NCT00908752
Treatments Being Tested
Part 1: To define the recommended dose of brivanib that can be safely admin...
Status
Completed
Location
Usc/Norris Comprehensive Cancer Center Hospital
Start Date
2008-05
Trial ID
NCT00594984
Treatments Being Tested
The purpose of this study is to determine if Brivanib is an effective treat...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2009-02-17
Trial ID
NCT00825955
Treatments Being Tested
The purpose of this study is to determine whether brivanib is an effective ...
Status
Terminated
Location
Local Institution
Start Date
2010-05
Trial ID
NCT01108705
RATIONALE: Brivanib may stop the growth of tumor cells by blocking some of ...
Status
Completed
Location
Tom Baker Cancer Centre
Start Date
2008-05-12
Trial ID
NCT00640471
Treatments Being Tested